[en] OBJECTIVE: To determine the effects of interleukin (IL)-6 and oncostatin M (OSM) added separately or in combination with IL-1beta on human osteoarthritic (OA) chondrocytes in alginate beads. DESIGN: Human chondrocytes were isolated from OA cartilage and cultured in alginate beads for 12 days, in the absence or in the presence of increasing amounts of IL-6 (20-500ng/ml) with its soluble receptor or OSM (0.1-10ng/ml) and with or without IL-1beta (1.7ng/ml). Aggrecan (AGG), transforming growth factor-beta1 (TGF-beta1), stromelysin-1 [matrix metalloprotease (MMP)-3], tissue inhibitor of metalloproteinases-1 (TIMP-1), macrophage inflammatory protein-1 beta (MIP-1beta), IL-6 and IL-8 productions were assayed by specific enzyme amplified sensitivity immunoassays. Prostaglandin (PG)E(2) was measured by a specific radioimmunoassay and nitrite (NO(2)(-)) by a spectrophotometric method based upon the Griess reaction. RESULTS: OSM, but not IL-6, decreased basal AGG and TGF-beta1 synthesis. Although IL-6 stimulated basal TIMP-1 production, it did not significantly modify MMP-3/TIMP-1 ratio. In contrast, 10ng/ml OSM highly increased TIMP-1 production, and decreased by half the ratio MMP-3/TIMP-1. IL-1beta highly stimulated *NO, IL-8, IL-6, MIP-1beta and PGE(2) synthesis but decreased AGG and TGF-beta1 production. Neither IL-6 nor OSM modulated IL-1beta-inhibitory effect on AGG production. IL-6, but not OSM, reversed IL-1beta-induced TGF-beta1 inhibition. At 1-10ng/ml, OSM significantly decreased IL-1beta-stimulated IL-8, MIP-1beta, PGE(2) and *NO production but amplified IL-1beta stimulating effect on IL-6 production. IL-6 had no effect on these parameters. CONCLUSIONS: OSM and IL-6, two glycoprotein 130 binding cytokines, show different activity profiles on OA chondrocytes, indicating that these cytokines could play different roles in the OA disease process.
Disciplines :
Rheumatology
Author, co-author :
Sanchez, Christelle ; Université de Liège - ULiège > Département des sciences de la motricité > Unité de recherche sur l'os et le cartillage (U.R.O.C.)
Deberg, Michelle ; Université de Liège - ULiège > Département des sciences de la motricité > Unité de recherche sur l'os et le cartillage (U.R.O.C.)
Devel, Philippe; Université de Liège - ULiège > Département des sciences de la motricité > Unité de recherche sur l'os et le cartillage (U.R.O.C.)
Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Epidémiologie et santé publique
Henrotin, Yves ; Université de Liège - ULiège > Département des sciences de la motricité > Unité de recherche sur l'os et le cartillage (U.R.O.C.)
Burton, Sandrine; Université de Liège - ULiège > Département des sciences de la motricité > Unité de recherche sur l'os et le cartillage (U.R.O.C.)
Language :
English
Title :
Differential Regulation of Chondrocyte Metabolism by Oncostatin M and Interleukin-6
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
E.M. Braunstein K.D. Brandt M. Albrecht MRI demonstration of hypertrophic articular cartilage repair in osteoarthritis Skeletal Radiol 19 1990 335-339
M.E. Adams K.D. Brandt Hypertrophic repair of canine articular cartilage in osteoarthritis after crucial ligament transection J Rheumatol 18 1991 428-435
F. Moldovan J.P. Pelletier J. Hambor J.M. Cloutier J. Martel-Pelletier Collagenase-3 (matrix metalloprotease 13) is preferentially localized in the deep layer of human arthritic cartilage in situ: in vitro mimicking effect by transforming growth factor beta Arthritis Rheum 40 1997 1653-1661
J.C. Fernandes J. Martel-Pelletier V. Lascau-Coman F. Moldovan D. Jovanovic J.P. Raynauld et al. Collagenase-1 and collagenase-3 synthesis in normal and early experimental osteoarthritic canine cartilage: an immunohistochemical study J Rheumatol 25 1998 1585-1594
H. Walter A. Kawashima W. Nebelung W. Neumann A. Roessner Immunohistochemical analysis of several proteolytic enzymes as parameters of cartilage degradation Pathol Res Pract 194 1998 73-81
C.A. Towle H.H. Hung L.J. Bonassar B.V. Treadwell D.C. Mangham Detection of interleukin-1 in the cartilage of patients with osteoarthritis: a possible autocrine/paracrine role in pathogenesis Osteoarthritis Cartilage 5 1997 293-300
J. Bocquet M. Daireaux M. Langris V. Jouis J.P. Pujol R. Beliard et al. Effect of a interleukin-1 like factor (mononuclear cell factor) on proteoglycan synthesis in cultured human articular chondrocytes Biochem Biophys Res Commun 134 1986 539-549
J.P. Pujol M. Brisset C. Jourdan J. Bocquet V. Jouis R. Beliard et al. Effect of a monocyte cell factor (MCF) on collagen production in cultured articular chondrocytes: role of prostaglandin E2 Biochem Biophys Res Commun 119 1984 499-508
Y. Henrotin D. De Groote A. Labasse S.E. Gaspar S.X. Zheng V.G. Geenen et al. Effects of exogenous IL-1β, TNFα, IL-6, IL-8 and LIF on cytokine production by human chondrocytes Osteoarthritis Cartilage 4 1996 163-173
R.M. Borzi I. Mazzetti L. Cattini M. Uguccioni M. Baggiolini A. Facchini Human chondrocytes express functional chemokine receptors and release matrix-degrading enzymes in response to C-X-C and C-C chemokines Arthritis Rheum 43 2000 1734-1741
M.L. Tiku J.B. Liesch F.M. Robertson Production of hydrogen peroxide by rabbit articular chondrocytes. Enhancement by cytokines J Immunol 145 1990 690-696
P. Silacci J.M. Dayer A. Desgeorges R. Peter C. Manueddu P.A. Guerne Interleukin (IL)-6 and its soluble receptor induce TIMP-1 expression in synoviocytes and chondrocytes, and block IL-1-induced collagenolytic activity J Biol Chem 273 1998 13625-13629
P.M. Villiger A.B. Kusari P. ten Dijke M. Lotz IL-1 beta and IL-6 selectively induce transforming growth factor-beta isoforms in human articular chondrocytes J Immunol 151 1993 3337-3344
H. Tilg E. Trehu M.B. Atkins C.A. Dinarello J.W. Mier Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55 Blood 83 1994 113-118
J.A. Solis-Herruzo R.A. Rippe L.W. Schrum P. de La Torre I. Garcia J.J. Jeffrey et al. Interleukin-6 increases rat metalloproteinase-13 gene expression through stimulation of activator protein 1 transcription factor in cultured fibroblasts J Biol Chem 274 1999 30919-30926
N. Franchimont S. Rydziel A.M. Delany E. Canalis Interleukin-6 and its soluble receptor cause a marked induction of collagenase 3 expression in rat osteoblast cultures J Biol Chem 272 1997 12144-12150
C.R. Flannery C.B. Little C.E. Hughes C.L. Curtis B. Caterson S.A. Jones IL-6 and its soluble receptor augment aggrecanase-mediated proteoglycan catabolism in articular cartilage Matrix Biol 19 2000 549-553
A.D. Rowan P.J. Koshy W.D. Shingleton B.A. Degnan J.K. Heath A.B. Vernallis et al. Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdown Arthritis Rheum 44 2001 1620-1632
G. Muller-Newen A. Kuster U. Hemmann R. Keul U. Horsten A. Martens et al. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses J Immunol 161 1998 6347-6355
A. Desgeorges C. Gabay P. Silacci D. Novick P. Roux-Lombard G. Grau et al. Concentrations and origins of soluble interleukin 6 receptor-alpha in serum and synovial fluid J Rheumatol 24 1997 1510-1516
P.A. Guerne A. Desgeorges J.M. Jaspar B. Relic R. Peter P. Hoffmeyer et al. Effects of IL-6 and its soluble receptor on proteoglycan synthesis and NO release by human articular chondrocytes: comparison with IL-1. Modulation by dexamethasone Matrix Biol 18 1999 253-260
T.E. Cawston V.A. Curry C.A. Summers I.M. Clark G.P. Riley P.F. Life et al. The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint Arthritis Rheum 41 1998 1760-1771
D.H. Manicourt P. Poilvache A. Van Egeren J.P. Devogelaer M.E. Lenz E.J. Thonar Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis Arthritis Rheum 43 2000 281-288
A.S. de Hooge F.A. van de Loo M.B. Bennink O.J. Arntz T.J. Fiselier M.J. Franssen et al. Growth plate damage, a feature of juvenile idiopathic arthritis, can be induced by adenoviral gene transfer of oncostatin M: a comparative study in gene-deficient mice Arthritis Rheum 48 2003 1750-1761
C. Plater-Zyberk J. Buckton S. Thompson J. Spaull E. Zanders J. Papworth et al. Amelioration of arthritis in two murine models using antibodies to oncostatin M. Arthritis Rheum 44 2001 2697-2702
P.M. Wallace J.F. Macmaster J.R. Rillema K.A. Rouleau M.B. Hanson S.A. Burstein et al. In vivo properties of oncostatin M Ann N Y Acad Sci 762 1995 42-54
O. Nemoto H. Yamada M. Mukaida M. Shimmei Stimulation of TIMP-1 production by oncostatin M in human articular cartilage Arthritis Rheum 39 1996 560-566
S. Varghese K. Yu E. Canalis Leukemia inhibitory factor and oncostatin M stimulate collagenase-3 expression in osteoblasts Am J Physiol 276 1999 E465-E471
P.J. Koshy C.J. Lundy A.D. Rowan S. Porter D.R. Edwards A. Hogan et al. The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin-1 and oncostatin M: a time-course study using real-time quantitative reverse transcription-polymerase chain reaction Arthritis Rheum 46 2002 961-967
J.B. Catterall S. Carrere P.J. Koshy B.A. Degnan W.D. Shingleton C.E. Brinckerhoff et al. Synergistic induction of matrix metalloproteinase 1 by interleukin-1alpha and oncostatin M in human chondrocytes involves signal transducer and activator of transcription and activator protein 1 transcription factors via a novel mechanism Arthritis Rheum 44 2001 2296-2310
W. Hui T. Cawston A.D. Rowan Transforming growth factor beta 1 and insulin-like growth factor 1 block collagen degradation induced by oncostatin M in combination with tumour necrosis factor alpha from bovine cartilage Ann Rheum Dis 62 2003 172-174
J.M. Milner S.F. Elliott T.E. Cawston Activation of procollagenases is a key control point in cartilage collagen degradation: interaction of serine and metalloproteinase pathways Arthritis Rheum 44 2001 2084-2096
W. Hui A.D. Rowan C.D. Richards T.E. Cawston Oncostatin M in combination with tumor necrosis factor alpha induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo Arthritis Rheum 48 2003 3404-3418
C. Langdon J. Leith F. Smith C.D. Richards Oncostatin M stimulates monocyte chemoattractant protein-1- and interleukin-1-induced matrix metalloproteinase-1 production by human synovial fibroblasts in vitro Arthritis Rheum 40 1997 2139-2146
P. Repovic K. Mi E.N. Benveniste Oncostatin M enhances the expression of prostaglandin E2 and cyclooxygenase-2 in astrocytes: synergy with interleukin-1beta, tumor necrosis factor-alpha, and bacterial lipopolysaccharide Glia 42 2003 433-446
C. Bernard R. Merval M. Lebret P. Delerive I. Dusanter-Fourt S. Lehoux et al. Oncostatin M induces interleukin-6 and cyclooxygenase-2 expression in human vascular smooth muscle cells: synergy with interleukin-1beta Circ Res 85 1999 1124-1131
Y.E. Henrotin A.H. Labasse J.M. Jaspar D.D. De Groote S.X. Zheng G.B. Guillou et al. Effects of three avocado/soybean unsaponifiable mixtures on metalloproteinases, cytokines and prostaglandin E2 production by human articular chondrocytes Clin Rheumatol 17 1998 31-39
C. Sanchez M.M. Mateus M.P. Defresne J.M. Crielaard J.Y. Reginster Y.E. Henrotin Metabolism of human articular chondrocytes cultured in alginate beads. Longterm effects of interleukin 1beta and nonsteroidal antiinflammatory drugs J Rheumatol 29 2002 772-782
C. Labarca K. Paigen A simple, rapid, and sensitive DNA assay procedure Anal Biochem 102 1980 344-352
D. Serteyn G. Deby-Dupont J. Pincemail E. Mottart C. Philippart M. Lamy Equine postanaesthetic myositis: thromboxanes, prostacyclin and prostaglandin E2 production Vet Res Commun 12 1988 219-226
L.C. Green D.A. Wagner J. Glogowski P.L. Skipper J.S. Wishnok S.R. Tannenbaum Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids Anal Biochem 126 1982 131-138
C. Sanchez M. Mathy-Hartert M.A. Deberg H. Ficheux J.Y. Reginster Y.E. Henrotin Effects of rhein on human articular chondrocytes in alginate beads Biochem Pharmacol 65 2003 377-388
L.C. Tetlow D.J. Adlam D.E. Woolley Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes Arthritis Rheum 44 2001 585-594
G.J. van Osch W.B. van den Berg E.B. Hunziker H.J. Hauselmann Differential effects of IGF-1 and TGF beta-2 on the assembly of proteoglycans in pericellular and territorial matrix by cultured bovine articular chondrocytes Osteoarthritis Cartilage 6 1998 187-195
L. Wang K.F. Almqvist E.M. Veys G. Verbruggen Control of extracellular matrix homeostasis of normal cartilage by a TGFbeta autocrine pathway. Validation of flow cytometry as a tool to study chondrocyte metabolism in vitro Osteoarthritis Cartilage 10 2002 188-198
M.W. Lark C.A. Saphos L.A. Walakovits V.L. Moore In vivo activity of human recombinant tissue inhibitor of metalloproteinases (TIMP). Activity against human stromelysin in vitro and in the rat pleural cavity Biochem Pharmacol 39 1990 2041-2049
M.C. Bell G.J. Carroll H.M. Chapman J.N. Mills W. Hui Oncostatin M induces leukocyte infiltration and cartilage proteoglycan degradation in vivo in goat joints Arthritis Rheum 42 1999 2543-2551
C. Langdon C. Kerr M. Hassen T. Hara A.L. Arsenault C.D. Richards Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo Am J Pathol 157 2000 1187-1196
A.D. Rowan W. Hui T.E. Cawston C.D. Richards Adenoviral gene transfer of interleukin-1 in combination with oncostatin M induces significant joint damage in a murine model Am J Pathol 162 2003 1975-1984
A.E. Koch S.L. Kunkel M.R. Shah R. Fu D.D. Mazarakis G.K. Haines et al. Macrophage inflammatory protein-1 beta: a C-C chemokine in osteoarthritis Clin Immunol Immunopathol 77 1995 307-314
M. Baggiolini I. Clark-Lewis Interleukin-8, a chemotactic and inflammatory cytokine FEBS Lett 307 1992 97-101
P. Ben-Av L.J. Crofford R.L. Wilder T. Hla Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis FEBS Lett 372 1995 83-87
R.M. Palmer A.G. Ferrige S. Moncada Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor Nature 327 1987 524-526
J.S. Beckman T.W. Beckman J. Chen P.A. Marshall B.A. Freeman Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide Proc Natl Acad Sci U S A 87 1990 1620-1624
H.M. Lander P. Sehajpal D.M. Levine A. Novogrodsky Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds J Immunol 150 1993 1509-1516
T.J. Brown J.M. Rowe J.W. Liu M. Shoyab Regulation of IL-6 expression by oncostatin M J Immunol 147 1991 2175-2180
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.
